Last month the Federal Circuit affirmed a PTAB inter partes review (IPR) decision finding that the University of Minnesota’s patent claim directed to the anti-cancer drug sofosbuvir was not adequately ...

Is it possible to patent biotech and pharmaceutical inventions globally using just one specification? John T Callahan and Ken Sakurabayashi of Sughrue Mion PLLC examine practice in the US, Japan and ...

The new patent-focused platform from Toppan Digital IP offers AI-driven translation and portfolio analytics. SVP Neil Simpkin explains how it’s helping the C-suite to manage portfolios. When ...

The Malaysian Intellectual Property Office (MyIPO) has not, until now, allowed a third party to inspect and obtain copies of any documents other than the granted patent specification, unless the ...

Too many entrepreneurs treat filing a patent as a milestone in itself—proof that their invention matters. But filing a patent too early, or without a clear business strategy, can create serious ...

“The CAFC found it plain… that Section 102(e)(1) was simply referencing a specific type of printed publication that becomes prior art as of the date it was filed.” Today, the U.S. Court of Appeals for ...

“Some would argue that a subsequent application is best served when it incorporates one or more prior applications by reference. The doctrine of incorporation by reference is a way to include matter ...

The Beijing IP court’s decision to revive a key semaglutide patent based on experimental data has far-reaching legal and economic implications, says Jennifer Che of Eagle IP. Recently, all eyes have ...